These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 9141751
21. Rubella control in Italy. Ciofi degli Atti M, Filia A, Revello MG, Buffolano W, Salmaso S. Euro Surveill; 2004 Apr; 9(4):19-21. PubMed ID: 15192262 [Abstract] [Full Text] [Related]
22. Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009. Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S. J Infect Dis; 2011 Jul; 204 Suppl 1():S24-7. PubMed ID: 21666168 [Abstract] [Full Text] [Related]
23. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003. Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R. Am J Infect Control; 2006 Nov; 34(9):588-92. PubMed ID: 17097454 [Abstract] [Full Text] [Related]
24. Congenital rubella syndrome and rubella in Vellore, South India. Chandy S, Abraham AM, Jana AK, Agarwal I, Kekre A, Korula G, Selvaraj K, Muliyil JP. Epidemiol Infect; 2011 Jun; 139(6):962-6. PubMed ID: 20642875 [Abstract] [Full Text] [Related]
25. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Song N, Gao Z, Wood JG, Hueston L, Gilbert GL, MacIntyre CR, Quinn HE, Menzies R, McIntyre P. Vaccine; 2012 Jun 08; 30(27):4073-8. PubMed ID: 22554644 [Abstract] [Full Text] [Related]
26. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran. Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S. J Clin Virol; 2005 Oct 08; 34(2):153-4. PubMed ID: 16076562 [Abstract] [Full Text] [Related]
27. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2005 Feb 25; 54(7):175-8. PubMed ID: 15729220 [Abstract] [Full Text] [Related]
28. Rubella seroprevalence among women aged 15-39 years in Morocco. Caidi H, Bloom S, Azilmaat M, Benjouad A, Reef S, El Aouad R. East Mediterr Health J; 2009 Feb 25; 15(3):526-31. PubMed ID: 19731768 [Abstract] [Full Text] [Related]
29. Costs of congenital rubella syndrome (CRS) in Oman: evidence based on long-term follow-up of 43 children. Al-Awaidy S, Griffiths UK, Nwar HM, Bawikar S, Al-Aisiri MS, Khandekar R, Mohammad AJ, Robertson SE. Vaccine; 2006 Sep 29; 24(40-41):6437-45. PubMed ID: 16814433 [Abstract] [Full Text] [Related]
30. Burden of Congenital Rubella Syndrome (CRS) in India: a systematic review. Dewan P, Gupta P. Indian Pediatr; 2012 May 29; 49(5):377-99. PubMed ID: 22700664 [Abstract] [Full Text] [Related]
31. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2000 Nov 24; 49(46):1048-50, 1059. PubMed ID: 11105768 [Abstract] [Full Text] [Related]
32. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience. Morice A, Carvajal X, León M, Machado V, Badilla X, Reef S, Lievano F, Depetris A, Castillo-Solórzano C. J Infect Dis; 2003 May 15; 187 Suppl 1():S158-63. PubMed ID: 12721908 [Abstract] [Full Text] [Related]
33. Further efforts in the achievement of congenital rubella syndrome/rubella elimination. Cozza V, Martinelli D, Cappelli MG, Tafuri S, Fortunato F, Prato R. Hum Vaccin Immunother; 2015 May 15; 11(1):220-4. PubMed ID: 25483539 [Abstract] [Full Text] [Related]
34. Rubella and congenital rubella syndrome--United States, January 1, 1991-May 7, 1994. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 1994 Jun 03; 43(21):391, 397-401. PubMed ID: 8183232 [Abstract] [Full Text] [Related]
35. Rubella vaccination programme in Malaysia: analysis of a seroprevalence study in an antenatal clinic. Sekawi Z, Muizatul WM, Marlyn M, Jamil MA, Ilina I. Med J Malaysia; 2005 Aug 03; 60(3):345-8. PubMed ID: 16379190 [Abstract] [Full Text] [Related]
36. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil. Minussi L, Mohrdieck R, Bercini M, Ranieri T, Sanseverino MT, Momino W, Callegari-Jacques SM, Schuler-Faccini L. Reprod Toxicol; 2008 Jan 03; 25(1):120-3. PubMed ID: 17977696 [Abstract] [Full Text] [Related]
37. The opportunity and obligation to eliminate rubella from the United States. Orenstein WA, Bart KJ, Hinman AR, Preblud SR, Greaves WL, Doster SW, Stetler HC, Sirotkin B. JAMA; 1984 Apr 20; 251(15):1988-94. PubMed ID: 6700103 [Abstract] [Full Text] [Related]
38. Surveillance of congenital rubella syndrome (CRS) in tertiary care hospitals in Hanoi, Vietnam during a rubella epidemic. Van Bang N, Van Anh NT, Van VT, Thai TT, Van Thuong N, Khandaker G, Elliott E. Vaccine; 2014 Dec 12; 32(52):7065-9. PubMed ID: 25444828 [Abstract] [Full Text] [Related]
39. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission. Reef SE, Redd SB, Abernathy E, Zimmerman L, Icenogle JP. Clin Infect Dis; 2006 Nov 01; 43 Suppl 3():S126-32. PubMed ID: 16998771 [Abstract] [Full Text] [Related]
40. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004. Best JM, Castillo-Solorzano C, Spika JS, Icenogle J, Glasser JW, Gay NJ, Andrus J, Arvin AM. J Infect Dis; 2005 Dec 01; 192(11):1890-7. PubMed ID: 16267759 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]